Tag Archives: melanoma

zoom
-

A New Era of Cancer Care

Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the body’s immune system to detect and fight cancer. Researchers have coined immunotherapy as the “beginning to the end of cancer” and we continue to see the space flourish.

Continue reading

zoom
-

Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and OncoSec’s role in the fight to end cancer. We discuss the advantages of intratumoral therapy, the future of cancer care, and how OncoSec is positioned to solve a great unmet need in oncology. Check out the full interview for more!

zoom
-

Smart Patients and OncoSec Medical

Smart Patients is an online platform that connects cancer patients and caregivers, allowing for an exchange of knowledge and support. Co-founded by Gilles Frydman and Roni Zeiger, MD – Google’s former chief health strategist – Smart Patients is a platform where users can share stories about their personal experiences, talk about the current leading research in the field, as well as access a library of clinical trials. By combining a message board community and archive of clinical trials, cancer affected patients, friends and family have an invaluable resource in their own home.

Continue reading

-

Blossom Ball Raises Over $150K for Cancer Research

cy13-gala-marysville-header216050

On May 11, I was honored to be involved with hosting the Annual American Cancer Society’s (ACS) Blossom Ball with my family, OncoSec Medical was one of the sponsors and together we helped raise over $150,000 for cancer research and funding. As a biopharmaceutical company developing advanced-stage immunotherapy to treat skin cancer, I believe it is very important to be involved as an individual and represent OncoSec Medical with both the ACS and the group CEO’s Against Cancer. Below is an excerpt from the speech I gave that night at the fundraiser, providing an outline on the CEO’s Against Cancer program.

Continue reading

zoom
-

Electroporation Key to Skin Cancer Treatment

One in five individuals is likely to suffer from skin cancer at some point in their lives, and the numbers are steadily increasing. Despite advances that have been made in sunscreen technology and growing public awareness of the need for sunscreen, data that were reported in Dermatology Times found that the average U.S. lifetime risk of invasive melanoma has increased from 1 in 600 in 1960 to 1 in 50 in 2008. As baby boomers grow older, there is an added risk that skin cancer and other sold tumor cancers will loom larger in their lives.

Continue reading

zoom
-

Building Relationships Between Biotech Corporations and Academia

I believe that integrating academic institutions with the research and development pipeline – and having access to their facilities and research potential – to be of major importance. With the foundation of the biotech industry situated in California and along the West Coast, the location offers an ideal pocket of innovation and growth, within the life science community. The areas of major consideration are the Bay Area, San Diego, and Seattle. These areas not only offer large, committed life science groups and thriving biotech companies and economies but also some of the best educational institutions in North America if not the world, when you look at the life sciences.

Continue reading

zoom
-

Introduction: Why Social-Digital now?

Every day, over 1,500 people in the US and an estimated 20,000 people around the world – just like you and me – will hear the news that they have been diagnosed with cancer. Thousands of them will be in the indication of melanoma or another lethal form of cancer. Those diagnosed with late stage cancer that has metastasized (spread to other parts of the body) will have to face the difficult fact that there is less than 50% chance that they will survive more than 5 years with this disease.

Continue reading

zoom
-

A New Opening in the Fight Against Solid Tumors

One in five people will suffer from skin cancer at some point in their lives, and the numbers are steadily increasing.  For example, despite advances in sunscreen technology and public awareness of the need for sunscreen, data that was recently reported in Dermatology Times reflects an increase in the average U.S. lifetime risk of one type of skin cancer—invasive melanoma—from 1/600 in 1960 to 1/50 in 2008.  As U.S. baby-boomers grow older, there is an added risk that skin cancer and other sold tumor cancers will loom larger in their lives.  Better treatments that are cost effective are therefore a high priority for the healthcare community to treat this expanding disease.

Continue reading